IGBA profile

ADOPTING A PATIENT CENTRIC APPROACH A B O U T Us The International Generic and Biosimilar medicines Association (IGBA) strengthens cooperation between associations representing manufacturers of generic and biosimilar medicines from around the world. Adopting a patient centric approach, IGBA is at the forefront of globally improving patients’ access to quality-assured, safe and cost-effective medicines by preserving competition as well as enabling innovation in the pharmaceutical sector and sustainable economic contributions for all stakeholders. MORE INFORMATION For more details, regarding IGBA and its member associations, see the IGBA website at: WWW.IGBAMEDICINES.ORG